Dose-dependent anti-obesity effect of the plant extract in subjects with abdominal obesity

Dose-dependent anti-obesity effect of the plant extract in subjects with abdominal obesity - Dose-dependent anti-obesity effect of the plant extract in subjects with abdominal obesity

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020188

Enrollment

Registered

2015-12-15

Start date

2016-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Subjects receive 3.2 g/day of placebo powder for 12 weeks, by dissolving the powder in 350 mL of hot water and replacing their daily tea drink with it. Subjects receive 4.2 g/day of study treatment po

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Visceral fat area not lower than 100 cm2

Exclusion criteria

Exclusion criteria: 1) Smoker 2) Heavy user of alcohol (more than two drinks a day) 3) Taking medicines or receiving health guidance for hypertension, diabetes, and/or hyperlipidemia 4) Taking drugs or functional food that may affect the trial 5) Participation in any clinical trial within 90 days of the commencement of the trial 6) In pregnancy or nursing a child 7) Cardiac, renal, and/or hepatic dysfunction 8) History of severe disease and/or major surgery

Design outcomes

Primary

Measure	Time frame
Visceral fat area at baseline, 8 and 12 weeks.	—

Secondary

Measure	Time frame
Body weight, body fat percentage, and waist circumference at baseline, 8 and 12 weeks.	—

Countries

Japan

Contacts

Public ContactFumiko Higashikawa

Hiroshima University, Institute of Biomedical & Health Sciences Project Research Center for Clinical Trial and Preventive Medicine

fumiko@hiroshima-u.ac.jp082-257-1533

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026